As of November 2024, Adverum Biotechnologies has a market cap of $706.18M. This makes Adverum Biotechnologies the world's 9499th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $205.08M | 169.59% |
2023 | $76.07M | 29.83% |
2022 | $58.60M | -67.05% |
2021 | $177.81M | -83.76% |
2020 | $1.10B | -5.90% |
2019 | $1.16B | 265.71% |
2018 | $318.24M | -10.00% |
2017 | $353.59M | 20.69% |
2016 | $292.98M | -69.54% |
2015 | $961.78M | -82.37% |
2014 | $5.46B | - |